Clinical Trial Detail

NCT ID NCT03871257
Title A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

astrocytoma

brain glioma

optic nerve glioma

Therapies

Carboplatin + Vincristine Sulfate

Selumetinib

Age Groups: child adult

No variant requirements are available.